MY115070A - Porcine reproductive and respiratory syndrome vaccine - Google Patents

Porcine reproductive and respiratory syndrome vaccine

Info

Publication number
MY115070A
MY115070A MYPI97000727A MYPI9700727A MY115070A MY 115070 A MY115070 A MY 115070A MY PI97000727 A MYPI97000727 A MY PI97000727A MY PI9700727 A MYPI9700727 A MY PI9700727A MY 115070 A MY115070 A MY 115070A
Authority
MY
Malaysia
Prior art keywords
respiratory syndrome
vaccine
porcine reproductive
syndrome vaccine
discloses
Prior art date
Application number
MYPI97000727A
Other languages
English (en)
Inventor
Richard A Hesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY115070(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MY115070A publication Critical patent/MY115070A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
MYPI97000727A 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine MY115070A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (1)

Publication Number Publication Date
MY115070A true MY115070A (en) 2003-03-31

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97000727A MY115070A (en) 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine

Country Status (19)

Country Link
EP (1) EP0894007A1 (es)
JP (1) JP3135069B2 (es)
KR (1) KR100297537B1 (es)
CN (1) CN1165342C (es)
AR (1) AR006023A1 (es)
AU (1) AU2277497A (es)
BG (1) BG64693B1 (es)
BR (1) BR9708443B1 (es)
CA (1) CA2248182C (es)
CO (1) CO4600644A1 (es)
CZ (1) CZ273798A3 (es)
EE (1) EE04741B1 (es)
HU (1) HUP9901958A3 (es)
MY (1) MY115070A (es)
PL (1) PL328627A1 (es)
RU (1) RU2187333C2 (es)
SK (1) SK119498A3 (es)
WO (1) WO1997031651A1 (es)
ZA (1) ZA971663B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
CA2650236C (en) 1999-04-22 2016-01-12 United States Of America, As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
TW200604526A (en) 2004-06-18 2006-02-01 Unviersity Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
WO2007002321A2 (en) 2005-06-24 2007-01-04 Regents Of The University Of Minnesota Prrs viruses, infectious clones, mutants thereof, and methods of use
CN101612395B (zh) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 一种培养敏感细胞生产蓝耳病疫苗的方法
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
CA2827337C (en) 2011-02-17 2019-07-09 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
EA038012B1 (ru) 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
KR101300528B1 (ko) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 액티노바실러스 플루로뉴모니애 감염 방지 및 처치용 조성물
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
CZ309704B6 (cs) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transportní médium pro transport a skladování virů
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
CA2121241C (en) * 1991-10-14 2007-12-04 Nicolaas Visser Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
CZ289743B6 (cs) * 1993-02-08 2002-03-13 Bayer Corporation Izolát viru vepřového reprodukčního a respiračního syndromu PRRSV, způsob kultivace PRRSV, tkáňová kultura, způsob přípravy vakcíny a vakcína obsahující PRRSV izolát
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
DE69522984T2 (de) * 1994-04-11 2002-04-25 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
EE9800267A (et) 1999-02-15
KR19990087432A (ko) 1999-12-27
WO1997031651A1 (en) 1997-09-04
BG64693B1 (bg) 2005-12-30
MX9807083A (es) 1998-12-31
BR9708443A (pt) 1999-08-03
BR9708443B1 (pt) 2012-06-12
EP0894007A1 (en) 1999-02-03
AU2277497A (en) 1997-09-16
HUP9901958A3 (en) 2000-04-28
RU2187333C2 (ru) 2002-08-20
CN1165342C (zh) 2004-09-08
KR100297537B1 (ko) 2001-10-26
PL328627A1 (en) 1999-02-15
CZ273798A3 (cs) 1999-02-17
JPH11506122A (ja) 1999-06-02
BG102809A (en) 1999-05-31
CO4600644A1 (es) 1998-05-08
CA2248182C (en) 2004-04-20
CN1216922A (zh) 1999-05-19
JP3135069B2 (ja) 2001-02-13
AR006023A1 (es) 1999-07-21
ZA971663B (en) 1997-08-26
EE04741B1 (et) 2006-12-15
CA2248182A1 (en) 1997-09-04
HUP9901958A2 (hu) 1999-10-28
SK119498A3 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
MY115070A (en) Porcine reproductive and respiratory syndrome vaccine
DE69619233D1 (en) Prrs-(porcine reproductive and respiratory syndrome)-virusvakzin
GR3035712T3 (en) European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
HK1029140A1 (en) Infectious cdna clone or north american porcine reproductive and respiratory syndrome (prrs)virus and uses thereof.
EP0676467A3 (en) European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
ZA986084B (en) CTL epitopes from EBV
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
PL317234A1 (en) Vaccines against papilloma virus
WO2003062407A8 (en) INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
AU7960598A (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ZA997011B (en) Attenuated forms of bovine viral diarrhea virus.
EP0835131A4 (en) DNA CLONE FOR SOUTH AFRICAN ARBOVIRUS No. 86
GB2332907B (en) EBV CTL Epitopes
EP0822980A4 (en) RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF
SG83740A1 (en) An attenuated porcine reproductive and respiratory syndrome virus strain and methods of use
NZ511168A (en) Recombinant CELO virus and CELO virus DNA